Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02529202 · ClinicalTrials.gov registry record · Early Phase 1
Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
A Early Phase 1 study of Hypoxic Ischemic Encephalopathy, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT02529202: Completed Early Phase 1 study of Hypoxic Ischemic Encephalopathy, sponsored by Seattle Children's Hospital.
NCT02529202 is a Early Phase 1 study of Hypoxic Ischemic Encephalopathy that has completed, run by Seattle Children's Hospital. The registered enrollment target is 7 participants, below the 83-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02529202, a Early Phase 1 study of Hypoxic Ischemic Encephalopathy, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to profile the pharmacokinetics of dexmedetomidine in newborns ≥36 weeks post-menstrual age during therapeutic hypothermia for hypoxic-ischemic encephalopathy.
Primary Outcome
Estimate PK parameter of AUC in newborns ≥36 weeks post-menstrual age with hypoxic-ischemic encephalopathy treated with a continuous dexmedetomidine infusion during therapeutic hypothermia.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-01 |
| Phase | Early Phase 1 |
What the finished NCT02529202 record still lists
NCT02529202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 83-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Hypoxic Ischemic Encephalopathy appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT02529202 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02529202 about?
NCT02529202 is a clinical study titled "Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia". The goal of this proposal is to profile the pharmacokinetics of dexmedetomidine in newborns ≥36 weeks post-menstrual age during therapeutic hypothermia for hypoxic-ischemic encephalopathy.
What is the current status of trial NCT02529202?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2016-03. Estimated completion is 2017-01.
What conditions does trial NCT02529202 study?
This clinical trial studies the following conditions: Hypoxic Ischemic Encephalopathy.
What interventions are being tested in trial NCT02529202?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT02529202?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02529202 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxic Ischemic Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02529202's enrollment target sits among peer trials
7 14th of 13 the lowest of 13 other Hypoxic Ischemic Encephalopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxic Ischemic Encephalopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
RECRUITING · Early Phase 1
-
The HIEnome Study: Genome Sequencing for Perinatal HIE
RECRUITING · NA
-
Dose Optimization of Caffeine for HIE
RECRUITING · Phase 1
-
Healthy Little Eyes
RECRUITING
-
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
RECRUITING · NA
-
Systemic Biomarkers of Brain Injury From Hyperammonemia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia